LifeStance Health Group annual return on equity
2021
2022
2023
2024
2025
LifeStance Health Group Return on Equity (ROE) Growth & History (LFST)
LifeStance Health Group's return on equity was 0.65% for fiscal 2025.
View full LifeStance Health Group company overviewLifeStance Health Group annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 0.65% | +4.65 pp |
| 2024 | 2024-12-31 | −4.00% | +8.64 pp |
| 2023 | 2023-12-31 | −12.64% | +1.43 pp |
| 2022 | 2022-12-31 | −14.07% | +30.49 pp |
| 2021 | 2021-12-31 | −44.56% | — |
LifeStance Health Group quarterly return on equity
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.60% | +1.86 pp |
| Q1 2026 | 2026-03-31 | 0.95% | +0.90 pp |
| Q4 2025 | 2025-12-31 | 0.77% | +1.73 pp |
| Q3 2025 | 2025-09-30 | 0.07% | +0.02 pp |
| Q2 2025 | 2025-06-30 | −0.26% | +1.37 pp |
| Q1 2025 | 2025-03-31 | 0.05% | +1.53 pp |
| Q4 2024 | 2024-12-31 | −0.96% | +2.16 pp |
| Q3 2024 | 2024-09-30 | 0.05% | +4.22 pp |
| Q2 2024 | 2024-06-30 | −1.63% | +1.40 pp |
| Q1 2024 | 2024-03-31 | −1.48% | +0.79 pp |
| Q4 2023 | 2023-12-31 | −3.12% | −0.06 pp |
| Q3 2023 | 2023-09-30 | −4.18% | −1.70 pp |
| Q2 2023 | 2023-06-30 | −3.03% | +1.44 pp |
| Q1 2023 | 2023-03-31 | −2.26% | +1.77 pp |
| Q4 2022 | 2022-12-31 | −3.06% | +3.93 pp |
| Q3 2022 | 2022-09-30 | −2.47% | +5.33 pp |
| Q2 2022 | 2022-06-30 | −4.47% | +1.04 pp |
| Q1 2022 | 2022-03-31 | −4.04% | — |
| Q4 2021 | 2021-12-31 | −6.99% | — |
| Q3 2021 | 2021-09-30 | −7.80% | — |
| Q2 2021 | 2021-06-30 | −5.51% | — |
LifeStance Health Group return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, LifeStance Health Group's return on equity increased from −44.56% to 0.65%, a change of +45.22 percentage points. The latest reported quarter, Q2 2026, shows 1.60%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LifeStance Health Group source filings ↗